methyl 2-(chloromethyl)-4-oxo-1,4-dihydroquinazoline-5-carboxylate, 95%, 100mg

Thiazole-5-carbohydrazide, 95.0%, 100mg

2-(3-Methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 100mg

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, 95%, 50mg

4-amino-3-(3-methoxyphenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 97%, 250mg

Methyl 5-bromo-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate, 98%, 1g

3-Bromoazetidine hydrochloride, 95.0%, 5g

5-Formylnicotinic acid, 97%, 25g

4-[4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1h-pyrazol-1-yl]benzoic acid, 97%, 100mg

Potassium standard solution, in 75 cSt mineral oil ROTI®Star, 50 g, plastic packaging.

(S)-Methyl 3-(1-amino-2-hydroxyethyl)benzoate hydrochloride, 97.0%, 50mg

Titanium(IV) oxide, min. 98%, ultra pure, 100 g, plastic packaging.

1-(3-Bromo-phenyl)-3,5-dimethyl-1H-pyrazole-4-carboxylic acid, 95.0%, 10g